Creative Medical Technology Holdings (CELZ) Income from Continuing Operations (2016 - 2025)

Creative Medical Technology Holdings has reported Income from Continuing Operations over the past 16 years, most recently at 2230048.0 for Q4 2025.

  • Quarterly Income from Continuing Operations rose 25.09% to 2230048.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6337382.0 through Dec 2025, up 4.21% year-over-year, with the annual reading at 6337382.0 for FY2025, 4.21% up from the prior year.
  • Income from Continuing Operations was 2230048.0 for Q4 2025 at Creative Medical Technology Holdings, down from 1235934.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 27836019.0 in Q1 2021 and troughed at 6215692.0 in Q4 2022.
  • The 5-year median for Income from Continuing Operations is 1505840.0 (2023), against an average of 458622.65.
  • Peak annual rise in Income from Continuing Operations hit 643.79% in 2021, while the deepest fall reached 566.91% in 2021.
  • Tracing CELZ's Income from Continuing Operations over 5 years: stood at 3875473.0 in 2021, then plummeted by 60.39% to 6215692.0 in 2022, then soared by 72.99% to 1678574.0 in 2023, then crashed by 77.34% to 2976814.0 in 2024, then grew by 25.09% to 2230048.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 2230048.0, 1235934.0, and 1233303.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.